pediTACTAL

TAA-specific cytotoxic T-lymphocytes · Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for pediTACTAL, covering 2024-10-22 to 2024-10-22. Get the full timeline:

Most recent: Clinical Trial Update: (TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL). [Phase 1]